- Quarterly Report (10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended December 31, 2011

Or

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from to

Commission file number: 0-20028

VALENCE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

Delaware	77-0214673
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

12303 Technology Blvd., Suite 950, Austin, Texas	78727
(Address of principal executive offices)	(Zip Code)

(512) 527-2900

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes o No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	o	Accelerated Filer	x
Non-Accelerated Filer	o	Smaller Reporting Company	o
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a Shell Company (as defined in Rule 12b-2 of the Exchange Act). o Yes x No

The number of shares of common stock, par value of $0.001 per share, outstanding at January 31, 2012 was 169,976,618.

VALENCE TECHNOLOGY, INC.

FORM 10-Q

INDEX

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited):

Condensed Consolidated Balance Sheets as of December 31, 2011 and March 31, 2011	3
Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Month Periods Ended December 31, 2011 and December 31, 2010	4
Condensed Consolidated Statements of Cash Flows for the Nine Month Periods Ended December 31, 2011 and December 31, 2010	5
Notes to Condensed Consolidated Financial Statements	6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3. Quantitative and Qualitative Disclosures about Market Risk	25

Item 4. Controls and Procedures	25

PART II – OTHER INFORMATION

Item 1. Legal Proceedings	26

Item 1A. Risk Factors	26

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	26

Item 3. Defaults Upon Senior Securities.	26

Item 4. [Removed and Reserved].	26

Item 5. Other Information.	26

Item 6. Exhibits.	27

Signatures and Certifications	28

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

Valence Technology, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share amounts)

	December 31,			March 31,
	2011			2011
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	3,209		$	2,915
Trade receivables, net of allowance of $494 and $361, respectively		5,684			13,615
Inventory, net		20,468			12,491
Prepaid and other current assets		2,280			2,661
Total current assets		31,641			31,682

Property, plant and equipment, net		3,834			4,192
Other long-term assets		240			143
Total assets	$	35,715		$	36,017

LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	9,255		$	9,150
Accrued expenses		4,558			6,063
Short-term debt, net of debt discount		2,953			10,686
Short-term debt to stockholder		2,000			—
Total current liabilities		18,766			25,899

Long-term interest payable to stockholder		32,586			30,350
Long-term debt to stockholder, net of debt discount		34,907			34,889
Other long-term liabilities		49			103

Commitments and contingencies

Preferred Stock:
Redeemable convertible preferred stock, $0.001 par value, 10,000,000 shares authorized, 861 issued and outstanding as of December 31, 2011 and March 31, 2011, liquidation value $8,610		8,610			8,610

Stockholders’ deficit:
Common stock, $0.001 par value, 200,000,000 shares authorized, 169,701,694 shares issued and 167,898,550 shares outstanding as of December 31, 2011 and 156,762,353 shares issued and 154,959,209 shares outstanding as of March 31, 2011		170			157
Additional paid-in-capital		552,816			537,957
Treasury shares, 1,803,144 at cost		(5,164	)		(5,164	)
Accumulated deficit		(603,903	)		(593,702	)
Accumulated other comprehensive loss		(3,122	)		(3,082	)
Total stockholders’ deficit		(59,203	)		(63,834	)
Total liabilities, preferred stock, and stockholders’ deficit	$	35,715		$	36,017

The accompanying notes are an integral part of these condensed consolidated financial statements.

Valence Technology, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except per share amounts)

( Unaudited )

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2011			2010			2011			2010

Revenue	$	8,505		$	13,754		$	31,053		$	31,977

Cost of sales		7,832			10,955			25,773			25,470

Gross margin		673			2,799			5,280			6,507

Operating expenses:
Research and product development		812			834			2,659			2,741
Sales and marketing		551			648			1,845			1,775
General and administrative		856			2,536			8,116			9,460
Impairment on long lived assets		97			1			314			11
Total operating expenses		2,316			4,019			12,934			13,987

Operating loss		(1,643	)		(1,220	)		(7,654	)		(7,480	)

Foreign exchange gain		127			288			615			645
Interest and other income		254			8			258			11
Interest and other expense		(1,155	)		(1,077	)		(3,290	)		(3,368	)
Net loss	$	(2,417	)	$	(2,001	)	$	(10,071	)	$	(10,192	)

Dividends on preferred stock		(43	)		(43	)		(130	)		(130	)

Net loss available to common stockholders, basic and diluted	$	(2,460	)	$	(2,044	)	$	(10,201	)	$	(10,322	)

Other comprehensive loss:
Net loss	$	(2,417	)	$	(2,001	)	$	(10,071	)	$	(10,192	)
Change in foreign currency translation adjustments		(27	)		(32	)		(40	)		(74	)
Comprehensive loss	$	(2,444	)	$	(2,033	)	$	(10,111	)	$	(10,266	)

Net loss per share available to common stockholders, basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.06	)	$	(0.07	)
Shares used in computing net loss per share available to common stockholders, basic and diluted		167,899			145,745			163,764			137,978

The accompanying notes are an integral part of these condensed consolidated financial statements.

Valence Technology, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

( Unaudited )

	Nine Months Ended December 31,
	2011			2010
Cash flows from operating activities:
Net loss	$	(10,071	)	$	(10,192	)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization		846			815
Bad debt expense, net of recoveries		411			76
Accretion of debt discount and other		286			157
Foreign exchange gain		(615	)		(645	)
Share-based compensation		516			650
Impairment on long-lived assets		314			11
Provision for obsolete inventory		648			1,221
Changes in operating assets and liabilities:
Trade receivables		7,521			(8,599	)
Inventory		(8,177	)		(9,924	)
Prepaid and other current assets		495			(912	)
Accounts payable		(60	)		9,371
Accrued expenses and long-term interest		362			2,947

Net cash used in operating activities		(7,524	)		(15,024	)

Cash flows from investing activities:
Purchases of property, plant and equipment		(606	)		(241	)

Net cash used in investing activities		(606	)		(241	)

Cash flows from financing activities:
Proceeds from short term debt to stockholder		4,000			5,000
Proceeds from stock option exercises		32			—
Proceeds from issuance of common stock, net of issuance costs		12,328			16,772
Payments of short-term debt		(8,000	)		(6,000	)

Net cash provided by financing activities		8,360			15,772

Effect of foreign exchange rates on cash and cash equivalents		64			60

Increase in cash and cash equivalents		294			567
Cash and cash equivalents, beginning of period		2,915			3,172
Cash and cash equivalents, end of period	$	3,209		$	3,739

Supplemental information:
Taxes paid	$	261		$	—
Interest paid	$	361		$	946
Cancellation of debt to stockholder in exchange for common shares	$	2,016		$	5,020

The accompanying notes are an integral part of these condensed consolidated financial statements.

Valence Technology, Inc.

Notes to Condensed Consolidated Financial Statements

December 31, 2011

(Unaudited)

1. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:

These interim condensed consolidated financial statements are unaudited but reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly the financial position of Valence Technology, Inc. and its subsidiaries (“Valence” or the “Company”) as of December 31, 2011, its consolidated results of operations for the three and nine month periods ended December 31, 2011 and December 31, 2010, and the consolidated cash flows for the nine month periods ended December 31, 2011 and December 31, 2010. All intercompany balances and transactions have been eliminated in consolidation. The Company owns 100% of the outstanding stock in its subsidiaries. Certain information and footnote disclosures normally included in the audited consolidated financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. Because all the disclosures required by accounting principles generally accepted in the United States are not included, these interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto in the Company’s Annual Report on Form 10-K as of and for the year ended March 31, 2011. The results for the three and nine month periods ended December 31, 2011 are not necessarily indicative of the results to be expected for the entire fiscal year ending March 31, 2012, or any other period. The year-end condensed consolidated balance sheet data as of March 31, 2011 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States.

2. BUSINESS AND BUSINESS STRATEGY:

The Company was founded in 1989 and develops, manufactures, and sells advanced energy systems utilizing the Company’s proprietary phosphate-based lithium-ion technology. The Company’s mission is to promote the wide adoption of high-performance, safe, long cycle life, environmentally friendly, low-cost energy storage systems. To accomplish this mission and address the significant market opportunity that the Company believes is available; the Company utilizes the numerous benefits of the Company’s latest energy storage technology, worldwide intellectual property portfolio and extensive experience of its management team. The Company is an international leader in the development of lithium iron magnesium phosphate advanced energy storage systems. The Company has redefined lithium battery technology and performance by marketing the industry’s first safe, reliable and rechargeable lithium iron magnesium phosphate battery for diverse applications, with special emphasis on the motive, marine, industrial and stationary markets.

In November 2009, the Company introduced a Revision 2 of its U-Charge ® Lithium Phosphate Energy Storage Systems, which became commercially available in the first quarter of 2010. The Company’s U-Charge ® systems feature its safe, long-life lithium phosphate technology which utilizes a phosphate-based cathode material. The Company believes that the improved features and functionality of the latest U-Charge ® lithium phosphate energy storage systems are well suited for electric vehicle (“EV”), plug-in hybrid electric vehicle (“PHEV”) and similar applications. U-Charge ® lithium phosphate energy storage systems address the safety and limited life weaknesses of other lithium technologies while offering a solution that is competitive in cost and performance. This Revision 2 of the Company’s U-Charge ® system builds upon these features and adds improvements in state of charge monitoring, cell pack balancing, battery monitoring and diagnostics, and certain field reparability.

In addition to the U-Charge ® family of products, the Company offers the materials, cells and systems, developed over 20 years, to address a large number of custom energy storage needs.

The Company’s business plan and strategy focuses on the generation of revenue from product sales, while controlling costs through partnerships with contract manufacturers and internal manufacturing efforts through its two wholly-owned subsidiaries in China. The Company expects to develop target markets through the sales of U-Charge ® systems and advanced energy storage systems based on programmable Command and Control Logic. In addition, the Company expects to pursue a licensing strategy to supply the lithium phosphate sector with advanced Valence material and components, including lithium phosphate cathode materials to fulfill other manufacturers’ needs.

The Company has the following wholly-owned subsidiaries: Valence Technology Cayman Islands Inc., Valence Technology (Suzhou) Co., Ltd., and Valence Energy-Tech (Suzhou) Co., Ltd.

Going Concern:

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred operating losses each year since its inception in 1989 and had an accumulated deficit of $603.9 million as of December 31, 2011. For the nine month periods ended December 31, 2011 and December 31, 2010, the Company sustained net losses available to common stockholders of $10.2 million and $10.3 million, respectively. These factors, among others, indicate that the Company may be unable to continue as a going concern for the next twelve months. The Company’s ability to continue as a going concern is contingent upon its ability to meet its working capital requirements. If the Company is unable to arrange for debt or equity financing on favorable terms or at all, the Company’s ability to continue as a going concern would be uncertain. These financial statements do not give effect to any adjustments to the amounts and classifications of assets and liabilities which might be necessary should the Company be unable to continue as a going concern.

Liquidity and Capital Resources:

At December 31, 2011, the Company’s principal sources of liquidity were cash and cash equivalents of $3.2 million. The Company does not expect that its cash and cash equivalents will be sufficient to fund its operating and capital needs for the next twelve months following December 31, 2011, nor does the Company anticipate its product sales during the remainder of fiscal year 2012 and fiscal year 2013 will be sufficient to cover its operating expenses. Historically, the Company has relied upon management’s ability to periodically arrange for additional equity or debt financing to meet the Company’s liquidity requirements.

During the nine month period ended December 31, 2011, the Company sold approximately 11.1 million shares of its common stock through the At Market Issuance Sales Agreement (the "Wm. Smith Agreement") with Wm. Smith & Co., as sales agent, for net proceeds of approximately $12.3 million. The shares sold under the Wm. Smith Agreement were registered under a Form S-3 Registration Statement filed with the SEC, which was declared effective on January 21, 2011. On May 25, 2011, Berg & Berg loaned $2.0 million to the Company. In connection with the loan, the Company executed a promissory note in favor of Berg & Berg. The promissory note was payable on August 15, 2011 and bore interest at a rate of 3.5% per annum. On August 15, 2011, that loan, plus accrued interest of $15,917 was surrendered by Berg & Berg in exchange for 1,832,653 shares of the Company’s common stock. On October 25, 2011, Berg & Berg loaned $2,000,000 to the Company. The promissory note was payable on January 15, 2012 and bore interest at 3.5% per annum. On January 13, 2012, the promissory note, plus accrued interest of $15,726, was surrendered by Berg & Berg in exchange for 2,078,068 shares of the Company’s common stock. The managing member of Berg & Berg is Carl E. Berg, who is the Chairman of the Company’s Board of Directors and the principal stockholder of the Company.

Unless the Company’s product sales are greater than management currently forecasts or there are other changes to the Company’s business plan, the Company will need to arrange for additional financing within the next twelve months to fund its operating and capital needs. This financing could take the form of debt or equity. Given the Company’s historical operating results and the amount of existing debt, as well as the other factors, the Company may not be able to arrange for debt or equity financing from third parties on favorable terms or at all.

The Company’s cash requirements may vary materially from those now planned because of changes in the Company’s operations, including the failure to achieve expected revenues, greater than expected expenses, changes in OEM relationships, market conditions, the failure to timely realize the Company’s product development goals, and other adverse developments. These events could have a negative effect on the Company’s available liquidity sources during the next twelve months.

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the revenues and expenses for the period. The Company has made significant estimates in determining the amount of allowance for doubtful accounts, inventory valuation adjustments and inventory overhead absorption as discussed in Note 5 of Notes to the Condensed Consolidated Financial Statements, warranty liabilities as discussed in Note 11 of Notes to the Condensed Consolidated Financial Statements, and share based compensation as discussed in Note 13 of Notes to the Condensed Consolidated Financial Statements. Actual results could differ from those estimates.

Reclassifications:

Where appropriate, the prior years’ financial statements have been reclassified to conform to current year presentation.

No changes have been made that impact the Company’s previously reported consolidated net revenue, loss from operations, net loss or net loss per share.

Revenue Recognition:

The Company generates revenues from sales of products including batteries and battery systems. Product sales are recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery or the transfer of title and risk of loss has occurred, seller’s price to the buyer is fixed and determinable, and collection is reasonably assured. For shipments where the transfer of title and risk of loss does not occur until the customer has accepted the product, the Company relies upon third party shipper notifications and notices of acceptance from the customer to recognize revenue. For all shipments, the Company estimates a return rate percentage based upon historical experience. From time to time, the Company provides sales incentives in the form of rebates or other price adjustments; these are generally recorded as reductions to revenue on the later of the date the related revenue is recognized or at the time the rebate or sales incentive is offered.

Recent Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” The amendments in this ASU require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of equity. ASU 2011-05 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2011, with early adoption permitted. The Company has not chosen to early adopt the provisions of this update. The future adoption of this update is not expected to have a material impact on the Company’s consolidated financial statements.

In May 2011, the FASB issued ASU 2011-04, “Amendments to Achieve Common Fair Value Measurement and disclosure Requirements in U. S. GAAP & IFRS,” which results in common fair value measurement and disclosure requirements in U.S. GAAP and IFRS. Consequently, the amendments change the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. ASU 2011-04 is effective for interim and annual periods beginning after December 15, 2011. The future adoption of ASU 2011-04 is not expected to have a material impact on the Company’s consolidated financial statements.

Net Loss per Share Available to Common Stockholders:

Net loss per share is computed by dividing the net loss by the weighted average shares of common stock outstanding during the periods. The dilutive effect of options and warrants to purchase common stock are excluded from the computation of diluted net loss per share, since their effect is antidilutive. The antidilutive instruments excluded from the diluted net loss per share computation were as follows during the:

	Three Months Ended				Nine Months Ended
	December 31,				December 31,
	2011		2010		2011		2010

Shares reserved for conversion of Series C-1 and Series C-2 preferred stock		3,628,634		3,628,634		3,628,634		3,628,634
Common stock options reserved		8,682,138		7,982,743		8,682,138		7,982,743
Warrants to purchase common stock		215,000		115,000		215,000		115,000
Total		12,525,772		11,726,377		12,525,772		11,726,377

The number of shares listed above as reserved upon conversion of Series C-1 Convertible Preferred Stock and Series C-2 Convertible Preferred Stock do not include shares related to accrued dividends that are convertible into shares of the Company’s stock at the election of the Company, subject to certain limitations. At December 31, 2011, up to approximately $1.1 million in accrued dividends would be convertible into 1,099,057 shares of common stock, at a price of $0.98 per share based on the closing sales price of the Company's common stock as quoted on the NASDAQ Capital Market on December 31, 2011.

4. IMPAIRMENT CHARGE:

In the nine month periods ended December 31, 2011 and December 31, 2010, the Company recorded impairment charges for idle production equipment in its China production facilities of $0.3 million and less than $0.1 million, respectively.

5. INVENTORY:

Inventory consisted of the following (in thousands) at:

	December 31, 2011		March 31, 2011
Raw materials	$	1,941	$	2,962
Work in process		4,755		6,282
Finished goods		13,772		3,247
Total inventory	$	20,468	$	12,491

Included in inventory at December 31, 2011 and March 31, 2011 were valuation allowances of $2.5 million and $1.3 million, respectively, to reduce their carrying values to the lower of cost or market. Management has valued overhead absorption related to work in process based on estimates of completion at December 31, 2011 and March 31, 2011.

6. PREPAID AND OTHER CURRENT ASSETS:

Prepaids and other current assets consisted of the following (in thousands) at:

	December 31, 2011		March 31, 2011
Other receivables	$	459	$	904
Deposits		967		733
Prepaid insurance		621		46
Other prepaid expenses		233		978
Total prepaids and other current assets	$	2,280	$	2,661

7. PROPERTY, PLANT AND EQUIPMENT:

Property, plant and equipment, net of accumulated depreciation and impairment, consisted of the following (in thousands) at:

	December 31, 2011			March 31, 2011
Leasehold improvements	$	1,040		$	992
Machinery and equipment		8,594			7,768
Office and computer equipment		2,386			2,324
Construction in progress		35			104
Property, plant and equipment, gross		12,055			11,188
Less: accumulated depreciation		(6,878	)		(6,000	)
Less: accumulated impairment charges		(1,343	)		(996	)
Total property, plant and equipment, net	$	3,834		$	4,192

Depreciation expense was approximately $0.3 million for each of the three month periods ended December 31, 2011 and December 31, 2010, and $0.8 million for each of the nine month periods ended December 31, 2011 and December 31, 2010.

8. ACCRUED EXPENSES:

Accrued expenses consisted of the following (in thousands) at:

	December 31, 2011		March 31, 2011
Accrued compensation	$	721	$	1,217
Professional services		214		222
Warranty reserve		1,156		1,653
Inventory received, not invoiced		474		893
Accrued dividends on preferred stock		1,077		947
Other accrued expenses		916		1,131
Total accrued expenses	$	4,558	$	6,063

9. DEBT:

Short-term debt, net of discount, consisted of the following (in thousands) at:

	December 31, 2011			March 31, 2011
Short term debt	$	3,000		$	11,000
Less: unaccreted debt discount		(47	)		(314	)
Short-term debt, net of debt discount	$	2,953		$	10,686

On July 13, 2005, the Company secured a $20.0 million loan (the “2005 Loan”) from SFT I, Inc., the full amount of which has been drawn down. The 2005 Loan is guaranteed by Carl E. Berg, Chairman of the Company's Board of Directors and the Company's principal shareholder. Interest is due monthly based on a floating interest rate equal to the greater of 6.75% or the sum of the LIBOR rate plus 4.0%. LIBOR was less than one percent at December 31, 2011, and the interest payable on the loan was at a rate of 6.75% at December 31, 2011. As of December 31, 2011, a total of $17.0 million in principal payments have been made on the 2005 Loan.

In connection with the 2005 Loan, SFT I, Inc. and Berg & Berg Enterprises, LLC (“Berg & Berg”) each received warrants to purchase 600,000 shares of the Company’s common stock at a price of $2.74 per share, the closing price of the Company’s common stock on July 12, 2005. The fair value assigned to these warrants, totaling approximately $2.0 million, has been recorded as a discount on the debt and will be accreted as interest expense over the life of the loan. On April 24, 2008, Berg & Berg exercised its warrants by purchasing 600,000 shares of the Company’s common stock for an aggregate purchase price of $1.6 million. In addition, SFT I, Inc. completed cashless exercises of its warrants on June 4, 2008 and June 27, 2008 and received a total of 230,767 common stock shares upon completion of the cashless exercises. Also, in connection with the 2005 Loan, the Company incurred a loan commitment fee and attorneys’ fees which, in addition to the interest rate cap agreement, have been recorded as a discount on the debt and will be accreted as interest expense over the life of the loan. The rate cap agreement terminated on August 10, 2008. Through December 31, 2011, a total of approximately $2.8 million has been accreted and included as interest expense. Interest payments on the 2005 Loan are currently being paid on a monthly basis.

The 2005 Loan has been amended several times since its origination, most recently on December 22, 2011 when the Company entered into an Amendment No. 4 to Loan and Security Agreement and Other Loan Documents (the “Amendment No. 4”) with iStar Tara LLC, a Delaware limited liability company (“iStar”), and Carl E. Berg, to amend the Loan and Security Agreement dated as of July 13, 2005 (as amended to date, the “Original Loan Agreement”) among the Company, iStar and Mr. Berg. Amendment No. 4 extended the maturity date of the three remaining principal payments of $1 million each (due in December 2011, January 2012 and February 2012) such that $1.5 million will be due on March 10, 2012 and the final $1.5 million will be due on April 10, 2012 (“New Maturity Dates”). The remainder of the principal and any other outstanding obligations under the Loan shall be payable in full on the New Maturity Dates.

In connection with the Loan, the Company had previously issued to iStar two Warrants to Purchase Common Stock of Valence Technology, Inc. (the “Warrants”), pursuant to which iStar may purchase up to 100,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at an exercise price of $1.45 per share and up to 115,000 shares of the Company’s Common Stock at an exercise price of $1.00 per share on or before January 11, 2014 and March 30, 2013, respectively. Under the terms in Amendment No. 4, the exercise periods of the two warrants that iStar or its affiliates hold have each been extended for one year to January 11, 2015 and March 30, 2014, respectively.

10. SHORT AND LONG TERM DEBT TO STOCKHOLDER:

Short-term debt to stockholder consisted of the following (in thousands) at:

		December 31, 2011				March 31, 2011
Short-term debt to stockholder		$	2,000			$	—

On October 25, 2011, Berg & Berg loaned $2,000,000 to the Company. In connection with the loan, the Company executed a promissory note in favor of Berg & Berg. The promissory note was payable on January 15, 2012 and bears interest at a rate of 3.5% per annum. On January 13, 2012, the promissory note plus accrued interest of $15,726, was surrendered by Berg & Berg in exchange for 2,078,068 shares of the Company’s common stock.

Long-term debt to stockholder, net of discount, consisted of the following (in thousands) at:

	December 31, 2011			March 31, 2011
2001 Loan	$	20,000			20,000
1998 Loan		14,950			14,950
Less: unaccreted debt discount		(43	)		(61	)
Long-term debt to stockholder, net of debt discount	$	34,907			34,889

In October 2001, the Company entered into a loan agreement (“2001 Loan”) with Berg & Berg. Under the terms of the agreement, Berg & Berg agreed to advance the Company funds of up to $20.0 million between the date of the agreement and September 30, 2003. Interest on the 2001 Loan accrues at 8.0% per annum, payable from time to time. The maturity date of the 2001 Loan has been extended multiple times, most recently on July 27, 2011, at which time Berg & Berg agreed to further extend the maturity date for the loan principal and interest from September 30, 2012 to September 30, 2015. Interest payments are currently being deferred, and are recorded as long term interest payable to stockholder on the consolidated balance sheet.

In conjunction with the 2001 Loan, Berg & Berg received a warrant to purchase 1,402,743 shares of the Company’s common stock at the price of $3.208 per share. These warrants were exercised on September 30, 2008 when Berg & Berg surrendered a short term note payable of $4.5 million to the Company as exercise consideration. The fair value assigned to these warrants, totaling approximately $5.1 million, has been reflected as additional consideration for the debt financing, recorded as a discount on the debt and accreted as interest expense over the life of the loan. Through December 31, 2011, a total of $5.1 million has been accreted and included as interest expense. The amount charged to interest expense on the outstanding balance of the loan for each of the three month periods ended December 31, 2011 and December 31, 2010 was $0.4 million. The amount charged to interest expense on the outstanding balance of the loan for each of the nine month periods ended December 31, 2011 and December 31, 2010 was $1.2 million. Interest payments on the loan are currently being deferred, and are recorded as long-term interest. The accrued interest amounts for the 2001 Loan were $16.0 million and $14.8 million as of December 31, 2011 and March 31, 2011, respectively.

In July 1998, the Company entered into an amended loan agreement (“1998 Loan”) with Berg & Berg that allows the Company to borrow, prepay and re-borrow up to $10.0 million principal under a promissory note on a revolving basis. In November 2000, the 1998 Loan agreement was amended to increase the maximum amount to $15.0 million. The 1998 Loan bears interest at one percent over lender’s borrowing rate (approximately 9.0 % at December 31, 2011). The maturity date of the 1998 Loan has been extended multiple times, most recently on July 27, 2011, at which time Berg & Berg agreed to further extend the maturity date for the loan principal and interest from September 30, 2012 to September 30, 2015. The amount charged to interest expense on the outstanding balance of the loan for each of the three month periods ended December 31, 2011 and 2010 was $0.3 million. The amount charged to interest expense on the outstanding balance of the loan for each of the nine month periods ended December 31, 2011 and December 31, 2010 was $1.0 million. Interest payments are currently being deferred, and are recorded as long term interest payable to stockholder on the consolidated balance sheet. The accrued interest amounts for the 1998 Loan were $16.6 million and $15.5 million as of December 31, 2011 and March 31, 2011, respectively.

All of the Company’s assets are pledged as collateral under the 2001 Loan and the 1998 Loan.

11. COMMITMENTS AND CONTINGENCIES:

Warranties:

The Company has established a warranty reserve in relation to the sale of its U-Charge ® Power Systems, custom packs, and other large-format power systems. The total warranty liability was $1.2 million and $1.7 million as of December 31, 2011 and March 31, 2011, respectively.

Litigation:

On January 31, 2007, the Company filed a claim against Phostech Lithium Inc. in the Federal Court in Canada (Valence Technology, Inc. v. Phostech Lithium Inc. Court File No. T-219-07) alleging infringement of Valence Canadian Patent 2,395,115 (‘115 Patent). Subsequently, on April 2, 2007, the Company filed an amended claim alleging additional infringement of the Company’s Canadian Patents 2,483,918 (‘918 Patent) and 2,466,366 (‘366 Patent). The trial took place in September 2010 and ended on October 1, 2010. On February 17, 2011, the Canadian Court ruled in the Company’s favor, finding that Phostech infringed Valence’s ‘115 Patent. The ‘918 Patent was held invalid. The ‘366 Patent was not held invalid, but no decision was rendered with respect to the infringement of the ‘366 Patent. An immediate injunction was imposed by the Trial Court on Phostech. Phostech twice appealed the imposition of the injunction and on the second appeal, the injunction was stayed by the Appellate Court, provided an expedited appeal would be undertaken and a bond posted by Phostech. The Appeal was heard on June 6, 2011. The Appellate Court denied the Appeal and affirmed the Trial Court Decision. The affirmation of the Trial Court’s decision permits the Company to seek monetary damages, reasonable attorney fees, costs and reinstated the injunction to stop Phostech from manufacturing, using and selling phosphate cathode material that infringes the valid Valence Canadian Patent 2,395,115. On October 7, 2011, the Company received a payment from Phostech of $532,388 for attorney's fees incurred by the Company during the litigation with Phostech, as determined by the Trial Court order dated September 7, 2011. This payment is reflected as a reduction of general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss during the nine month period ended December 31, 2011. During the three month period ended December 31, 2011, the Company received an additional $251,709 from Phostech as a partial payment of damages, and the determination of additional damages is continuing. This payment was reflected in interest and other income in the condensed consolidated statement of operations and comprehensive loss during the three and nine month periods ended December 31, 2011.

On February 14, 2006, Hydro-Quebec filed an action against the Company in the United States District Court for the Western District of Texas (Hydro-Quebec v. Valence Technology, Civil Action No. A06CA111). An amended complaint was filed April 13, 2006. A stay imposed due to the USPTO reexaminations of the two patents was lifted following completion of the reexaminations. On January 8, 2009, Hydro-Quebec filed a second amended complaint, wherein Hydro-Quebec alleges that the cathode technology utilized in all of the Company’s commercial products, infringes U.S. Reexamined Patent Nos. 5,910,382 and 6,514,640 exclusively licensed to Hydro-Quebec. Hydro-Quebec seeks injunctive relief and monetary damages. The Company has filed a response denying the allegations in the second amended complaint. A Markman hearing to determine the scope of the asserted claims in the two reexamined patents was completed in January 2010. The Special Master submitted recommended findings from the Markman Hearing to the Court in August 2010 and a Court hearing was held on those findings in November 2010. On April 27, 2011, the Court issued its order adopting the report of the Special Master. The Court set a trial date for October 2012. The case is now in the discovery phase.

On October 4, 2011, the Company was served with a complaint filed by Hydro-Quebec in the United States District Court for the Northern District of Texas (Hydro-Quebec v. A123 Systems, Inc., Valence Technology, Inc., Segway, Inc., and Texas Seg LLC., Civil Action No. 3:11-CV-1217 B). Hydro-Quebec seeks injunctive relief and monetary damages. The Complaint alleges the Company is infringing five US Patents of the University of Texas. The five US Patents are all related to and continuations of the original UT Patent of Goodenough that has been asserted in the above-noted litigation in the Austin, Texas Federal District Court. The Company intends to vigorously defend against the allegations in the complaint and has filed a Motion to Transfer the Case to the Western District of Texas in Austin, Texas.

The Company is subject, from time to time, to various claims and litigation in the normal course of business. In the Company’s opinion, all pending legal matters will not have a material adverse impact on its consolidated financial statements. However, the outcome of any litigation is inherently uncertain and there can be no assurance as to the ultimate outcome of any such legal matters.

12. REDEEMABLE CONVERTIBLE PREFERRED STOCK:

On November 30, 2004, the Company issued 431 shares of Series C-1 Convertible Preferred Stock, with a stated value of $4.3 million, and 430 shares of Series C-2 Convertible Preferred Stock, with a stated value of $4.3 million. When issued, the Series C-1 Convertible Preferred Stock and Series C-2 Convertible Preferred Stock were convertible into common stock at $4.00 per share. Each series carries a 2% annual dividend rate, payable quarterly in cash or shares of common stock, and were redeemable on December 15, 2005. The preferred shares are currently outstanding and subject to redemption or conversion at the holder’s discretion.

Pursuant to assignment agreements entered into between the Company and Berg & Berg Enterprises, LLC on July 14, 2005 and December 14, 2005, Berg & Berg purchased all of the outstanding Series C-1 Convertible Preferred Stock and Series C-2 Convertible Preferred Stock from its original holder. Pursuant to the terms of the assignment agreement, Berg & Berg agreed that the failure of the Company to redeem the preferred stock on December 15, 2005 did not constitute a default under the certificate of designations and has waived the accrual of any default interest applicable in such circumstance. In exchange, the Company has agreed (i) that the Series C-1 Convertible Preferred Stock may be converted, at any time, into the Company’s common stock at the lower of $4.00 per share or the closing bid price of the Company’s common stock on December 13, 2005, which was $1.98 per share, and (ii) that the Series C-2 Convertible Preferred Stock may be converted, at any time, into the Company’s common stock at the lower of $4.00 per share or the closing bid price of the Company’s common stock on July 13, 2005, which was $2.96 per share. Berg & Berg has agreed to allow dividends to accrue on the preferred stock. At December 31, 2011 and March 31, 2011, $1.1 million and $0.9 million in preferred stock dividends had accrued, respectively.

13. SHARE-BASED COMPENSATION:

In October 1997, the Board of Directors adopted the 1997 Non-Officer Stock Option Plan (the “1997 Plan”). The 1997 Plan terminated on October 3, 2007, and as of December 31, 2011, a total of 28,900 shares had been issued and are outstanding under this plan, and no shares were available to be granted under this plan.

In January 2000, the Board of Directors adopted the 2000 Stock Option Plan (the “2000 Plan”). The plan terminated in January 2010, and as of December 31, 2011, a total of 2,694,903 shares had been issued and are outstanding under this plan, and no shares were available to be granted under this plan.

On April 30, 2009, the Board of Directors adopted the Valence Technology, Inc. 2009 Equity Incentive Plan (the “2009 Plan”). The 2009 Plan is a broad-based incentive plan that provides for granting stock options, stock awards, performance awards, and other stock-based awards and substitute awards to employees, service providers and non-employee directors. Option awards granted under the 2009 Plan typically have required service periods between three and four years, and all options granted under this plan have 10 year contractual lives, unless otherwise specified. When awards are exercised, the Company settles the awards by issuing shares of the Company’s common stock. The 2009 Plan also has provisions for the granting of performance based awards, where certain milestones or conditions, as determined by the Company’s Compensation Committee or management, are required to be achieved or met in order for the option award to vest. The maximum number of shares of the Company’s common stock initially reserved for issuance under the 2009 Plan is 3,000,000 shares. The 2009 Plan contains an “evergreen” provision whereby the number of shares of common stock available for issuance under the 2009 Plan shall automatically increase on the first trading day of April of each fiscal year during the term of the 2009 Plan, beginning with the fiscal year ending March 31, 2011, by an amount (the “Annual Increase Amount”) equal to the lesser of (i) one percent (1%) of the total number of shares of common stock outstanding on the last trading day in March of the immediately preceding fiscal year, (ii) 1,500,000 shares and (iii) such lesser amount if set by the Board. On April 1, 2011, an additional 1.5 million shares were added to the 2009 Plan pursuant to the Annual Increase Amount. The maximum number of shares of common stock that may be issued under the 2009 Plan pursuant to the exercise of incentive stock options is the lesser of (A) 3,000,000 shares, increased on the first trading day of April of each fiscal year during the term of the 2009 Plan, beginning with the fiscal year ending March 31, 2011, by the Annual Increase Amount, and (B) 16,500,000 shares. The 2009 Plan also contains an automatic option grant program for the Company’s non-employee directors. Under the automatic option grant program, each individual who first becomes a non-employee board member at any time after the effective date of the 2009 Plan will receive an option grant to purchase 100,000 shares of common stock on the date such individual joins the board. In addition, on the date of each annual stockholders meeting held after the effective date of the 2009 Plan, each non-employee director who continues to serve as a non-employee director will automatically be granted an option to purchase 50,000 shares of common stock, provided such individual has served on the board for at least six months. All employees, service providers and directors of the Company and its affiliates are eligible to participate in the 2009 Plan. This plan will terminate on April 29, 2019. The 2009 Plan was approved by the Company’s stockholders at the annual meeting of stockholders on September 8, 2009.

In the nine month period ended December 31, 2011 the Compensation Committee granted 222,220 performance based restricted stock units ("RSUs") to a certain executive. This award has performance based vesting conditions, which are based on the Company obtaining certain quarterly revenue targets in order for pre-specified amounts of the stock units to vest. The minimum performance targets for the three month periods ended September 30, 2011 and December 31, 2011 were not met and 111,110 RSUs expired. As of December 31, 2011, a total of 111,110 RSUs remain outstanding and subject to vesting if the pre-specified performance targets are achieved in the upcoming quarters.

In the nine month period ended December 31, 2011, the Compensation Committee granted stock appreciation rights ("SARs") to certain China employees. These SARs vest in equal annual installments over a five year service period, and they entitle the recipient to receive a cash settlement equal to any increase in the Company's stock price, as quoted on the NASDAQ Capital Market. A total of 84,600 SARs were granted during the nine month period ended December 31, 2011, and 84,600 SARs remain outstanding as of December 31, 2011.

In the nine month period ended December 31, 2011, a total of 41,665 stock options were exercised for net proceeds of $32,498. In the nine month period ended December 31, 2011, the Company granted 1,226,470 stock options and RSUs under the 2009 Plan, and as of December 31, 2011, 2,345,285 total stock options and RSUs are outstanding and 2,113,050 shares remain available for grant under the 2009 Plan.

Share-based compensation expense included in cost of sales and operating expenses is as follows for the three and nine month periods ended (in thousands):

	Three Months Ended				Nine Months Ended
	December 31,				December 31,
	2011		2010		2011		2010
Cost of sales	$	19	$	3	$	49	$	14
Research and product development		23		39		62		142
Sales and marketing		25		18		83		63
General and administrative		65		149		322		431
Total share-based compensation expense	$	132	$	209	$	516	$	650

14. RELATED PARTY TRANSACTIONS:

On December 22, 2011, the Company entered into an Amendment No. 4 with iStar and Carl Berg to amend the Original Loan Agreement among the Company, iStar and Mr. Berg. Amendment No. 4 extended the maturity date of the three remaining principal payments of $1 million each (due in December 2011, January 2012 and February 2012) such that $1.5 million will be due on March 10, 2012 and the final $1.5 million will be due on April 10, 2012. The remainder of the principal and any other outstanding obligations under the Loan shall be payable in full on the New Maturity Dates.

In connection with the Loan, the Company had previously issued to iStar two Warrants pursuant to which iStar may purchase up to 100,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at an exercise price of $1.45 per share and up to 115,000 shares of the Company’s Common Stock at an exercise price of $1.00 per share on or before January 11, 2014 and March 30, 2013, respectively. Under the terms in Amendment No. 4, the exercise periods of the two warrants that iStar or its affiliates hold have each been extended for one year to January 11, 2015 and March 30, 2014, respectively.

On October 25, 2011, Berg & Berg loaned $2.0 million to the Company in exchange for a promissory note issued by the Company. The promissory note was payable on January 15, 2012, and bore interest at 3.5% per annum. On January 13, 2012, that loan, plus accrued interest of $15,726 was surrendered by Berg & Berg in exchange for 2,078,068 shares of the Company’s common stock.

On May 25, 2011, Berg & Berg loaned $2.0 million to the Company. In connection with the loan, the Company executed a promissory note in favor of Berg & Berg. The promissory note was payable on August 15, 2011 and bore interest at a rate of 3.5% per annum. On August 15, 2011, that loan, plus accrued interest of $15,917 was surrendered by Berg & Berg in exchange for 1,832,653 shares of the Company’s common stock.

15. SEGMENT AND GEOGRAPHIC INFORMATION:

The Company’s chief operating decision maker is its Chief Executive Officer, who reviews operating results to make decisions about resource allocation and to assess performance. The Company’s chief operating decision maker views results of operations of a single operating segment, the development and marketing of the Company’s lithium phosphate technology. The Company’s Chief Executive Officer has organized the Company functionally to develop, market, and manufacture lithium phosphate products.

Long-lived asset information by geographic area is as follows (in thousands):

	December 31, 2011		March 31, 2011
United States	$	274	$	301
Asia		3,555		3,885
Other		5		6
Total	$	3,834	$	4,192

Revenues by geographic area are as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 31,				December 31,
	2011		2010		2011		2010
United States	$	4,940	$	12,248	$	22,115	$	28,045
Europe		3,080		1,449		8,253		3,442
Other		485		57		685		490
Total	$	8,505	$	13,754	$	31,053	$	31,977

16. SIGNIFICANT CUSTOMERS:

In the three and nine month periods ended December 31, 2011 and 2010, a limited number of the Company’s customers have accounted for a significant portion of revenues as follows:

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2011			2010			2011			2010
Segway, Inc.		20	%		21	%		19	%		30	%
Rubbermaid Medical Solutions		16			**			15			**
PVI		16			**			12			**
Howard Medical Solutions		14			12			12			**
Smith Electric Vehicles*		—			48			16			40

* Previous periods listed Tanfield PLC as a separate customer, but it is now included in Smith Electric Vehicles.

** Less than 10%

A limited number of the Company’s customers have accounted for a significant portion of accounts receivable as follows at:

	December 31, 2 011			March 31, 2011
Segway, Inc.		21	%		11	%
Rubbermaid Medical Solutions		21			12
Howard Medical Solutions		20			**
PVI		**			13
Smith Electric Vehicles*		**			44

* Previous periods listed Tanfield PLC as a separate customer, but it is now included in Smith Electric Vehicles.

** Less than 10%

17. SUBSEQUENT EVENTS:

On October 25, 2011, Berg & Berg loaned $2.0 million to the Company. On January 13, 2012, that loan, plus accrued interest of $15,726 was surrendered by Berg & Berg in exchange for 2,078,068 shares of the Company’s common stock.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q, which we refer to as this “Report,” contains statements that constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. The words “may,” “will,” “expect,” “intend,” “estimate,” “continue,” “anticipate,” “predict,” “believe” and similar expressions and variations thereof are intended to identify forward-looking statements. These statements appear in a number of places in the Report and include statements regarding the intent, belief or current expectations of Valence Technology, Inc., to which we refer in this Report as “Valence,” the “Company,” “we” or “us,” with respect to, among other things:

●		trends affecting our financial condition or results of operations;
●		our product development strategies;
●		trends affecting our manufacturing capabilities;
●		trends affecting the commercial acceptability of our products; and
●		our business and growth strategies.

You are cautioned not to put undue reliance on our forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those projected in this Report. Factors that could cause our actual results to differ materially include those discussed under “Risk Factors,” which include, but are not limited to the following:

●		our ability to develop and market products that compete effectively in targeted market segments;
●		market acceptance of our current and future products;
●		our ability to meet customer demand;
●		our ability to perform our obligations under our loan agreements;
●		a loss of one of our key customers;
●		our ability to implement our long-term business strategy that will be profitable and/or generate sufficient cash flow;
●		the ability of our vendors to provide conforming materials for our products on a timely basis;
●		the loss of any of our key executive officers;
●		our ability to manage our foreign manufacturing and development operations;
●		international business risks;
●		our ability to attract skilled personnel;
●		our ability to protect and enforce our current and future intellectual property;
●		our ability to meet the continued listing requirements of the NASDAQ Capital Market;
●		our need for additional, dilutive financing or future acquisitions; and
●		future economic, business and regulatory conditions.

We believe that it is important to communicate our future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. The factors discussed under “Risk Factors” in this Report, as well as any cautionary language in this Report and any of our other reports or filings, including our Annual Report on Form 10-K, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we described in our forward-looking statements.

The following discussion should be read in conjunction with our financial statements and related notes, which are a part of this Report. Except as required by law, we undertake no obligation to publicly revise these forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances that arise after the date hereof. The results for the three and nine month periods ended December 31, 2011 are not necessarily indicative of the results to be expected for the entire fiscal year ended March 31, 2012 or any other period.

Overview

We were founded in 1989 and develop, manufacture and sell advanced energy storage systems utilizing our proprietary phosphate-based lithium-ion technology. Our mission is to promote the wide adoption of high-performance, safe, environmentally friendly energy storage systems. To accomplish our mission and address the significant market opportunity we believe is available we utilize the numerous benefits of our latest energy storage technology, worldwide intellectual property portfolio and extensive experience of our management team. We are a global leader in the development of patented lithium iron magnesium phosphate advanced energy storage systems. We have redefined lithium battery technology and performance by marketing the industry’s first safe, reliable and rechargeable lithium iron magnesium phosphate battery for diverse applications, with special emphasis on motive, marine, industrial, military and stationary markets.

Valance is a diverse, vertically aligned company. From our patented cathode materials to our standard family of scalable U-Charge ® systems and customs systems designed for specific applications, we offer commercially proven solutions. For many applications our scalable U-Charge ® systems, complete with programmable Battery Management Systems (“BMS”), are the logical choice in avoiding the expense and long development cycles of custom systems. However, when a custom system is required, Valence has the technology, tools and experience to fulfill our customers’ requirements.

We believe that the improved features and functionality of our lithium iron magnesium phosphate energy storage systems are well suited for motive, marine, industrial, military, stationary and other applications that require safety, improved performance and long run times.

Following years of commercial use, we believe our experience is paving the way for the lower cost and higher performance solutions that our next generation lithium vanadium technologies will offer.

Strategy

Our business plan and strategy focuses on the generation of revenue from sales of advanced energy storage systems, while controlling costs through partnerships with contract manufacturers and internal manufacturing efforts through our two wholly-owned subsidiaries in Suzhou, China. We expect to develop target markets through the sales of our scalable U-Charge ® and custom energy storage systems, complete with our programmable BMS. In addition, as the alternative energy sector matures, we expect to pursue licensing or other alliance opportunities to expand our presence in the lithium phosphate sector.

Key elements of our business strategy include:

●

Develop and market differentiated battery solutions for a wide array of applications that leverage the advantages of our technologies. We are committed to the improvement of our technologies, our energy storage systems, integration of our energy storage systems into our customer applications and further development of worldwide suppliers to serve the rapidly expanding lithium phosphate sector. Our product development and marketing efforts are focused on large-format battery solutions, such as our scalable U-Charge ® systems, and custom energy storage systems such as the next generation London hybrid double deck bus manufactured by Wrightbus. Our products are positioned to fulfill the needs of a wide variety of applications as alternative energy devices enter commercial markets.

●

Manufacture high-quality, cost-competitive products using a combination of owned facilities and contract manufacturing facilities. Our products are manufactured in China, using both internal and contract manufacturing resources. Our company-owned China facility includes two plants: one manufactures our advanced lithium iron magnesium phosphate materials with our patented carbon-thermal reduction process, and the second manufactures our advanced standard large-format packs such as U-Charge ® and custom packs for customers such as Segway Inc. (“Segway”). We have arrangements with contract manufacturers for cylindrical cell production. We believe this manufacturing strategy will allow us to directly control our intellectual property and operations management as well as deliver high-quality products that meet the needs of a broad range of customers and applications.

Our business strategy is being implemented in phases. We are currently moving beyond Phase 1 toward Phase 2:

●

Phase 1: Our current business strategy is focused on developing applications that deliver an improved energy storage solution to address the desired performance goals of the end user. We are utilizing our mature technology, the intellectual property developed during the 21 year life of Valence, and critical “on-the-road”, “on-line” experience to expand our commercial opportunities. Our scalable U-Charge ® Systems are designed for a broad base of motive, marine, military, industrial, and stationary applications offering improved performance, safety, long life, lower lifetime cost and no maintenance. During this phase, we are relying on the word-of-mouth recommendations of our early customers, the engineering benefits we enjoy with emerging development partners and reliable in-use experience to expand our presence in target global markets.

●

Phase 2: Looking toward the immediate future, our business strategy will entail the commercialization of our patented Lithium Vanadium Phosphate (“LVP”) and Lithium Vanadium Phosphate Fluoride (“LVPF”) cathode materials into large-format, high capacity cells. These materials will offer improved performance and the protection for our customers afforded by our worldwide intellectual patent portfolio.

We believe our commercial growth strategy will allow us to expand into emerging market applications through the sales of Valence products based on our differentiated technology, design and application engineering capabilities, global fulfillment services and our proven lower cost, high volume manufacturing. Further, we believe Valence is well positioned to license our technology to key component and material manufacturers, such as manufacturers of lithium phosphate cells to further accelerate growth within the worldwide lithium phosphate sector.

We believe we are well positioned for growth due to the following:

●

Leading Technology . We believe that our phosphate-based lithium-ion technologies and manufacturing processes offer many performance and economic advantages over competing battery technologies. The safety, long life and other advantages inherent in our technology enable the design of large-format, lower cost lithium-ion energy systems. As the first company in the battery industry to commercialize phosphates, we believe that we have a significant advantage in terms of time to market as well as chemistry, advanced energy storage system development and manufacturing expertise.

●

New Market Opportunities . Our technology enables the production of high energy density, large-format batteries while reducing the safety concerns presented by oxide-based lithium-ion batteries. Consequently, our lithium phosphate technology energy and power systems can be designed into a wide variety of products and markets. In 2007, we concluded that it would be difficult to predict which markets or devices would adopt lithium solutions early and which markets or devices would follow later. Also, standards had not yet developed in the lithium sector. Based on what we knew of commercial fleet needs compared to our capabilities, we chose to pursue fleets aggressively. We felt fleets would serve as a proving ground of our technology and business economics. We believe this approach has served us well and prepared us to pursue additional opportunities as they materialize.

●

New Valence Market Focus . Over 20 years we have transitioned from a technology developer to a commercial provider of advanced energy storage systems. Our patent portfolio continues to expand. Our technology is maturing and has been tested for years in commercial applications. Our manufacturing capability has matured, is ISO 9001 certified, and can be easily expanded as markets develop. Our application engineers are recognized experts in the integration of our systems into customer applications. We have strengthened our marketing and sales resources. Our full service fulfillment services in Europe, North America and China are on-line. We have developed what we believe to be a world-class supplier base of raw materials and components to support our manufacturing, and our senior management team has extensive international technology and business experience.

●

Lithium Phosphate-Based Technology . We developed and commercialized the first lithium phosphate energy power systems with our lithium iron magnesium phosphate technology. We have two following generations of cathode materials in our proprietary Lithium Vanadium Phosphate and Lithium Vanadium Fluorophosphates cathode applications, both positioned to advance lithium phosphate cathode applications to the next level of applications and use.

Our business headquarters is in Austin, Texas. Our materials research and development center is in Las Vegas, Nevada. Our European sales and OEM manufacturing support center is in Mallusk, Northern Ireland. Our manufacturing and product development center is in Suzhou, China. We have the following subsidiaries: Valence Technology Cayman Islands, Inc., Valence Technology (Suzhou) Co., Ltd., and Valence Energy-Tech (Suzhou) Co., Ltd.

Going Concern

As a result of our limited cash resources and history of operating losses there is substantial doubt about our ability to continue as a going concern. We presently have no further commitments for financing by our Chairman Carl Berg and or his affiliates. Recently, we have depended on sales of our common stock under the At-Market Issuance Agreement with Wm. Smith & Co and short term loans and stock sales with Mr. Berg. If we are unable to obtain additional financing from Mr. Berg, through our agreement with Wm. Smith & Co, or others on terms acceptable to us, or at all, we may be forced to cease all operations and liquidate our assets.

At December 31, 2011, our principal sources of liquidity were cash and cash equivalents of $3.2 million. We do not expect that our cash and cash equivalents will be sufficient to fund our operating and capital needs for the next twelve months following December 31, 2011, nor do we anticipate product sales during fiscal year 2012 or fiscal year 2013 will be sufficient to cover our operating expenses. Historically, we have relied upon our management’s ability to periodically arrange for additional equity or debt financing to meet our liquidity requirements. Our cash requirements may vary materially from those now planned because of changes in our operations, including the failure to achieve expected revenues, greater than expected expenses, changes in OEM relationships, market conditions, the failure to timely realize our product development goals, and other adverse developments. These events could have a negative effect on our available liquidity sources during the next twelve months.

Basis of Presentation, Critical Accounting Policies and Estimates

We prepare our consolidated financial statements in conformity with generally accepted accounting principles in the United States (“U.S.”). The preparation of our financial statements requires us to make estimates and assumptions that affect reported amounts. We believe our most critical accounting policies and estimates relate to revenue recognition, impairment of long-lived assets, inventory reserves, inventory overhead absorption, warranty liabilities, and share-based compensation expense. Our accounting policies are described in the Notes to Condensed Consolidated Financial Statements, Note 3, Summary of Significant Accounting Policies. The following further describes the methods and assumptions we use in our critical accounting policies and estimates.

Revenue Recognition:

We generate revenues from sales of products including batteries and battery systems. Product sales are recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery or transfer of title and risk of loss has occurred, seller’s price to the buyer is fixed and determinable, and collection is reasonably assured. For shipments where the transfer of title and risk of loss does not occur until the customer has accepted the product, we rely upon third party shipper notifications and notices of acceptance from the customer to recognize revenue. For all shipments, we estimate a return rate percentage based upon historical experience. From time to time, we provide sales incentives in the form of rebates or other price adjustments; these are generally recorded as reductions to revenue on the latter of the date the related revenue is recognized or at the time the rebate or sales incentive is offered.

Impairment of Long-Lived Assets:

We perform a review of our long-lived tangible and intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparison of their carrying amounts to future undiscounted cash flows that the assets are expected to generate. If long-lived assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the assets exceeds its fair value and is recorded in the period the determination was made.

Inventory:

Inventory is stated at the lower of cost (determined using the first-in, first-out method) or market.

Warranty:

We record warranty liabilities at the time of sale for the estimated costs that may be incurred under our basic limited warranty. The warranty terms and conditions generally provide for replacement of defective products. Factors that affect our warranty liability include the number of units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy our warranty obligations. Each quarter, we re-evaluate our estimates to assess the adequacy of our recorded warranty liabilities and adjust the amounts as necessary.

Share-Based Compensation:

We measure share-based compensation expense for all share-based awards granted based on the estimated fair value of those awards at grant-date. The fair values of stock option awards are estimated using a Black-Scholes valuation model. The compensation costs are recognized net of any estimated forfeitures on a straight-line basis over either the employee’s requisite service period, or other such vesting requirements as are stipulated in the stock option award agreements. Forfeiture rates are estimated at grant date based on historical experience and adjusted in subsequent periods for any differences in actual forfeitures from those estimates. See Note 13, Share-Based Compensation of Notes to Condensed Consolidated Financial Statements for further discussion of share-based compensation.

Results of Operations

The following table sets forth, for the periods indicated, the percentages of net sales represented by certain items reflected in our condensed consolidated statements of operations:

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2011			2010			2011			2010
Revenue		100	%		100	%		100	%		100	%
Gross margin		8			20			17			20
Operating expenses		27			29			42			44
Operating loss		(19	)		(9	)		(25	)		(23	)
Net loss		(28	)%		(15	)%		(32	)%		(32	)%

Revenues and Gross Margin

Revenues . Revenue totaled $8.5 million and $13.8 million for the three month periods ended December 31, 2011 and December 31, 2010, respectively. Revenues decreased by $5.3 million, or 38%, in the three month period ended December 31, 2011, compared to the three month period ended December 31, 2010. This decrease was primarily due to decreased shipments to Smith Electric Vehicles U.S. (“Smith”), and Segway Inc. (“Segway”). Revenue from Smith was zero in the three month period ended December 31, 2011 compared to $6.5 million in the three month period ended December 31, 2010. Revenue from Segway was $1.7 million in the three month period ended December 31, 2011 compared to $2.9 million in the three month period ended December 31, 2010. These decreases in revenue were partially offset by increases in revenue in the three month period ended December 31, 2011, compared to the three month period ended December 31, 2010, to PVI and Rubbermaid Medical Solutions (“Rubbermaid”). Revenue from PVI was $1.4 million in the three month period ended December 31, 2011, compared to $0.1 million in the three month period ended December 31, 2010. Revenue from Rubbermaid was $1.3 million in the three month period ended December 31, 2011 compared to $0.5 million in the three month period ended December 31, 2010.

Revenue totaled $31.1 million and $32.0 million for the nine month periods ended December 31, 2011 and December 31, 2010, respectively. Revenues decreased by $0.9 million, or less than three percent, in the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010. The decrease in revenues in the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010 was primarily due to decreased revenue from Smith and Segway. Smith revenue was $5.1 million in the nine month period ended December 31, 2011 compared to $12.9 million in the nine month period ended December 31, 2010. Revenue from Segway was $5.8 million in the nine month period ended December 31, 2011 compared to $9.7 million in the nine month period ended December 31, 2010. These decreases in revenue were offset primarily by increases in revenue in the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010, to Rubbermaid, PVI, and BJ Technologies, a subsidiary of Beneteau S.A. ("Beneteau"). Revenue from Rubbermaid was $4.6 million in the nine month period ended December 31, 2011 compared to $0.6 million in the nine month period ended December 31, 2010. Revenue from PVI was $3.8 million in the nine month period ended December 31, 2011, compared to $0.3 million in the nine month period ended December 31, 2010. Revenue from Beneteau was $1.2 million in the nine month period ended December 31, 2011, compared to less than $0.1 million in the nine month period ended December 31, 2010.

Sales to Segway accounted for 20% of our total product sales for the three month period ended December 31, 2011 and 21% of our total product sales for the three month period ended December 31, 2010. Sales to Howard accounted for 14% of our total product sales for the three month period ended December 31, 2011 and 12% of our total product sales for the three month period ended December 31, 2010. Sales to Rubbermaid accounted for 16% of our total product sales for the three month period ended December 31, 2011 and less than 10% of our total product sales for the three month period ended December 31, 2010. Sales to PVI accounted for 16% of our total product sales for the three month period ended December 31, 2011 and less than 10% of our total product sales for the three month period ended December 31, 2010.

Sales to Smith accounted for 16% of our total product sales for the nine month period ended December 31, 2011 and 40% of our total product sales for the nine month period ended December 31, 2010. Sales to Segway accounted for 19% of our total product sales for the nine month period ended December 31, 2011 and 30% of our total product sales for the nine month period ended December 31, 2010. Sales to Howard accounted for 12% of our total product sales for the nine month period ended December 31, 2011, and less than 10% of our total product sales for the nine month period ended December 31, 2010. Sales to Rubbermaid accounted for 15% of our total product sales for the nine month period ended December 31, 2011 and less than 10% of our total product sales for the nine month period ended December 31, 2010. Sales to PVI accounted for 12% of our total product sales for the nine month period ended December 31, 2011 and less than 10% of our total product sales for the nine month period ended December 31, 2010.

Licensing and royalty revenues were less than 10% of our reported revenues in current and prior period and are no longer disclosed separately.

Gross Margin . Gross margin was $0.7 million in the three month period ended December 31, 2011, compared to $2.8 million in the three month period ended December 31, 2010, a $2.1 million decrease. Gross margin as a percentage of revenue was 8% for the three month period ended December 31, 2011 compared to 20% for the three month period ended December 31, 2010. Gross margin was $5.3 million in the nine month period ended December 31, 2011, compared to $6.5 million in the nine month period ended December 31, 2010, a $1.2 million decrease. Gross margin as a percentage of revenue was 17% for the nine month period ended December 31, 2011, and 20% for the nine month period ended December 31, 2010. During each of the three and nine month ended December 31, 2011 and December 31, 2010, less than $0.1 million of share-based compensation was allocated to cost of goods sold.

During the three and nine month periods ended December 31, 2011 gross margin as a percentage of revenue decreased compared to the same periods in 2010. The main reason for the decrease in gross margin as a percentage of revenue in the three and nine months periods ended December 31, 2011, compared to the same periods in the previous year was due to decreased utilization of our manufacturing facilities as we decreased production levels to meet the reduced demand for our products in the fiscal year 2011 periods. This reduction in production volume resulted in less fixed manufacturing overhead costs being absorbed into inventory. The dollar decreases in gross margin in the three and nine month periods ended December 31, 2011, compared to the three and nine month periods ended December 31, 2010 were mainly attributable to the decreased revenue in the current period and the decreased utilization of our production facilities in the current periods. We expect cost of sales, as a percentage of sales, to be higher in the remainder of fiscal year 2012, compared to fiscal year 2011 due to lower expected revenue and production volumes. In addition, we expect increased pricing pressure to negatively impact our gross margins in the upcoming quarters as we compete for additional business and continue to keep the existing business we have from our current customers. We did not experience any material effect of inflation on our gross margin or operating expenses in the two most recent fiscal years.

Operating Expenses

The following table presents the changes in operating expenses for the three and nine months ended December 31, 2011 and 2010, respectively (dollars in thousands):

	Three Months Ended										Nine Months Ended
	December 31, 2011		December 31, 2010		Change			% Change			December 31, 2011		December 31, 2010		Change			% Change
Research and product development	$	812	$	834	$	(22	)		(3	)%	$	2,659	$	2,741	$	(82	)		(3	)%
Sales and marketing		551		648		(97	)		(15	)		1,845		1,775		70			4
General and administrative		856		2,536		(1,680	)		(66	)		8,116		9,460		(1,344	)		(14	)
Impairment of long lived assets		97		1		96			9,600			314		11		303			2,755
Total operating expenses	$	2,316	$	4,019	$	(1,703	)		(42	)%	$	12,934	$	13,987	$	(1,053	)		(8	)%

During the three and nine month periods ended December 31, 2011, total operating expenses were 27% and 42% of revenue, respectively, compared to 29% and 44% of revenue during the same periods in the previous year. During the three month period ended December 31, 2011, compared to the three month period ended December 31, 2010, operating expenses were $1.7 million lower due to the recovery of a bad debt expense in the three month period ended December 31, 2011 related to a disputed accounts receivable balance owed by Smith totaling $1.9 million. During the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010, operating expenses decreased $1.1 million, mainly due to decreased expenses associated with ongoing litigation concerning our intellectual property, and the $0.5 million reimbursement of our litigation expenses associated with our lawsuit against Phostech

Research and Product Development. Research and product development expenses consist primarily of personnel, equipment and materials to support our efforts to develop battery chemistry and products, as well as to improve our manufacturing processes. Research and product development costs were $0.8 million and $2.7 million during each of the three and nine month periods ended December 31, 2011 and December 31, 2010, respectively. During each of the three and nine month periods ended December 31, 2011 and December 31, 2010, less than $0.1 million of share-based compensation was allocated to research and development expenses. We expect research and development expenses to remain relatively flat for the remainder of fiscal year 2012.

Sales and Marketing . Sales and marketing expenses consist primarily of costs related to sales and marketing personnel, public relations and promotional materials. Sales and marketing expenses were $0.6 million and $1.8 million for each of the three and nine month periods ended December 31, 2011 and December 31, 2010, respectively. During each of the three and nine month periods ended December 31, 2011, and December 31, 2010, less than $0.1 million of share-based compensation was allocated to sales and marketing expenses. We expect sales and marketing expenses remain relatively flat for the remainder of fiscal year 2012.

General and Administrative . General and administrative expenses consist primarily of salaries, share-based compensation and other related costs for finance, human resources, facilities, accounting, information technology, legal, and corporate-related expenses. General and administrative expenses were $0.9 million and $8.1 million for the three and nine month periods ended December 31, 2011, respectively, and $2.5 million and $9.5 million for the three and nine month periods ended December 31, 2010, respectively. The $1.7 million decrease in general and administrative expenses during the three month period ended December 31, 2011, compared to the same period in the previous year, is related to a $1.9 million decrease in our bad debt expense in the 2011 period, which related to the recovery of disputed amounts owed to us by Smith and other customers. The $1.3 million decrease in general and administrative expenses in the nine month period ended December 31, 2011 compared to the same period in the previous year, is related to a decrease in expenses associated with litigation involving our intellectual property, in addition to a $0.5 million reimbursement of our litigation expenses associated with our lawsuit against Phostech, partially offset by higher bad debt expense in the nine month period ended December 31, 2011 compared to the nine month period December 31, 2010. During the three and nine month periods ended December 31, 2011, $0.1 million and $0.3 million of share-based compensation was allocated to general and administrative expenses, respectively, compared to $0.1 million and $0.4 million in the three and nine month periods ended December 31, 2010, respectively.

Impairment of Long Lived Assets. In the three and nine month periods ended December 31, 2011, the impairment expense for long lived assets was $0.1 million and $0.3 million, respectively. These impairments related to manufacturing equipment in our China production facilities which were deemed unusable due to changes in our manufacturing processes or due to the replacement of certain manufacturing equipment with newer equipment.

Liquidity and Capital Resources

Liquidity

At December 31, 2011, our principal source of liquidity was cash and cash equivalents of $3.2 million. We do not expect our cash and cash equivalents will be sufficient to fund our operating and capital needs for the next twelve months following December 31, 2011, nor do we anticipate that product sales during the remainder of fiscal year 2012 or fiscal year 2013 will be sufficient to cover our operating expenses. Historically, we have relied upon management’s ability to periodically arrange for additional equity or debt financing to meet our liquidity requirements. Unless our product sales are greater than management currently forecasts or there are other changes to our business plan, we will need to arrange for additional financing to fund operating and capital needs. This financing could take the form of debt or equity. Given our historical operating results and the amount of our existing debt, as well as the other factors, we may not be able to arrange for debt or equity financing on favorable terms or at all.

On February 22, 2008, we entered into an At Market Issuance Sales Agreement (the “Wm. Smith Agreement”) with Wm. Smith & Co., as sales agent (the “Sales Agent”), which has been amended several times, most recently on June 17, 2011, pursuant to Amendment No. 4 to At Market Issuance Sales Agreement (the “Amendment”), under which we may issue and sell up to 30,000,000 shares of common stock in a series of transactions over time as we may direct through the Sales Agent. Unless we and the Sales Agent agree to a lesser amount with respect to certain persons or classes of persons, the compensation to the Sales Agent for sales of common stock sold pursuant to the Wm. Smith Agreement will be 6.0% of the gross proceeds of the sales price per share. During the nine months ended December 31, 2011, we sold 11.1 million shares for net proceeds of $12.3 million under the Wm. Smith Agreement. As of December 31, 2011, we had sold a total of 24.6 million shares under this arrangement for aggregate gross proceeds of $42.2 million. As of December 31, 2011, 5.4 million shares of common stock remain available for issuance and sale under the Wm. Smith Agreement. The Wm. Smith Agreement will terminate upon the sale of all shares authorized for sale thereunder, unless earlier terminated by one or both parties as permitted thereunder.

We filed a Form S-3 Registration Statement with the SEC utilizing a “shelf” registration process, which Registration Statement was declared effective on January 21, 2011 (the “New Registration Statement”). Pursuant to the new Registration Statement, we may sell debt or equity securities described in the accompanying prospectus in one or more offerings up to a total public offering price of $50.0 million. The New Registration Statement replaced our Form S-3 Registration Statement that expired on January 22, 2011 (the “Expired Registration Statement”). We believe that the New Registration Statement provides us additional flexibility with regard to potential financings that we may undertake when market conditions permit or that our financial condition may require.

Our cash requirements may vary materially from those now planned because of changes in our operations, including our failure to achieve expected revenues greater than expected expenses, changes in OEM relationships, market conditions, our ability to collect our accounts receivables in a timely fashion, the failure to timely realize our product development goals, our stock price, and other adverse developments. These events could have a negative effect on our available liquidity sources during the next twelve months.

The following table summarizes our statement of cash flows for the nine month periods ended December 31, 2011 and 2010 (in thousands):

	Nine Months Ended December 31,
	2011			2010
Net cash flows provided by (used in):
Operating activities	$	(7,524	)	$	(15,024	)
Investing activities		(606	)		(241	)
Financing activities		8,360			15,772
Effect of foreign exchange rates		65			60
Net increase in cash and cash equivalents	$	295		$	567

Our use of cash from operations for the nine month period ended December 31, 2011 was $7.5 million, compared to $15.0 million for the nine month period ended December 31, 2010. Our cash used for operating activities for the nine month period ended December 31, 2011 decreased by $7.5 million compared to the nine month period ended December 31, 2010, primarily due to an increase in cash from trade receivables in the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010, partially offset by a decrease in cash from accounts payable in the nine month period ended December 31, 2011, compared to the nine month period ended December 31, 2010.

In the nine month periods ended December 31, 2011 and December 31, 2010, we used $0.6 million and $0.2 million, respectively, for investing activities. These expenditures primarily relate to the purchases of fixed assets in our U.S. and China facilities.

We obtained cash from financing activities in the amounts of $8.4 million and $15.8 million during the nine month periods ended December 31, 2011 and 2010, respectively. In the nine month period ended December 31, 2011, we sold approximately 11.1 million shares of our common stock with proceeds net of commissions totaling $12.3 million under the At Market Issuance Sales Agreement discussed in more detail above. In the nine month period ended December 31, 2010, we sold approximately 1.0 million shares with proceeds net of commissions of $1.3 million under the At Market Issuance Sales Agreement. In addition, we sold 3.3 million shares under a Common Stock Purchase agreement dated October 14, 2009 to Seaside 88, LP, with gross proceeds of $3.0 million, in the nine month period ended December 31, 2010. During the nine month period ended December 31, 2011, Berg & Berg loaned us $4.0 million in two separate transactions in exchange for promissory notes. On May 25, 2011, Berg & Berg loaned us $2.0 million in exchange for a promissory note payable on August 15, 2011. On August 15, 2011, Berg & Berg surrendered this promissory note in exchange for a total of 1,832,653 shares of our common stock. The total purchase price of the shares was the surrender of promissory note dated May 25, 2011, and accrued interest of $15,917, for a total purchase price of $2,015,917. On October 24, 2011, Berg & Berg loaned us $2.0 million in exchange for a promissory note payable on January 15, 2012 which bore interest at 3.5% per annum. During the nine month period ended December 31, 2010, Berg & Berg purchased a total of 9,170,959 shares of our common stock for cash at a price per share ranging from $0.76 to $1.04, for an aggregate purchase price of $7,508,390.

We used $8.0 million and $6.0 million in cash in the nine month periods ended December 31, 2011, and December 31, 2010, respectively, to make scheduled monthly principal payments on our loan to iStar.

Capital Commitments and Debt

At December 31, 2011 we had no significant commitments for capital expenditures for the next 12 months.

Our cash obligations for short-term and long-term debt and interest, gross of unaccreted discount, consisted of the following (in thousands):

	December 31, 2011
Short-term debt	$	3,000
Short-term debt to stockholder*		2,000
Long term interest payable to stockholder		32,586
Long-term debt to stockholder		34,950
Total	$	72,536

* Converted to shares of common stock on January 13, 2012.

Repayment obligations of short-term and long-term debt principal, by fiscal year, as of December 31, 2011 are (in thousands):

			Fiscal Year
	Total		2012		2013		2014		2015		2016 and thereafter
Short-term principal repayment	$	3,000	$	1,500	$	1,500	$	—	$	—	$	—
Short-term principal repayment to stockholder*		2,000		2,000		—		—		—		—
Long-term principal repayment to stockholder		34,950		—		—		—		—		34,950
Total	$	39,950	$	3,500	$	1,500	$	—	$	—	$	34,950

* Converted to shares of common stock on January 13, 2012.

Inflation

Historically, our operations have not been materially affected by inflation. However, our operations may be affected by inflation in the future.

Tabular Disclosure of Contractual Obligations

The following table sets forth, as of December 31, 2011, our scheduled principal, interest and other contractual annual cash obligations due for each of the periods indicated below (in thousands):

			Payments Due by Period
	Total		Less than 1 year		1-3 Years		3-5 Years		More than 5 Years
Contractual obligations:
Short-term debt to stockholder*	$	2,000	$	2,000	$	—	$	—	$	—
Short-term debt, net of discount		2,953		2,953		—		—		—
Long-term debt to stockholder, net of discount		34,907		—		—		34,907		—
Long-term interest payable to stockholder		32,599		13		—		32,586		—
Operating lease obligations		1,506		839		667		—		—
Purchase obligations		12,407		12,407		—		—		—
Total	$	86,372	$	18,212	$	667	$	67,493	$	—

* Converted to shares of common stock on January 13, 2012.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exchange Rate Risk . As a result of our foreign operations, we have significant expenses, assets and liabilities that are denominated in foreign currencies. A significant number of our employees are located in Asia. Therefore, a substantial portion of our payroll as well as certain other operating expenses are paid in the China RMB. Additionally, we purchase materials and components from suppliers in Asia. While we pay many of these suppliers in U.S. dollars, their costs are typically based upon the local currency of the country in which they operate. The majority of our revenues are received in U.S. dollars.

As a consequence, our gross profit, operating results, profitability and cash flows are adversely affected when the dollar depreciates relative to other foreign currencies. We have a particularly significant currency rate exposure to changes in the exchange rate between the RMB and the U.S. dollar. For example, to the extent that we need to convert U.S. dollars for our operations, appreciation of the RMB against the U.S. dollar would have an adverse effect on the amount we receive from the conversion.

We have not used any forward contracts, currency borrowings or derivative financial instruments for purposes of reducing our exposure to adverse fluctuations in foreign currency exchange rates.

Interest Rate Risk . Our exposure to interest rate risk primarily relates to a $20.0 million loan agreement we entered into on July 13, 2005 with iStar with an adjustable interest rate equal to the greater of 6.75% or the sum of the LIBOR rate plus 4.0% (LIBOR was less than 1% at December 31, 2011). The current loan balance as of December 31, 2011 was $3.0 million, plus accrued interest.

We are exposed to financial market risks, including changes in foreign currency exchange rates and interest rates.

The following table presents the principal cash flows by year of maturity for our total debt obligations held at December 31, 2011 (in thousands):

			Expected Maturity Dates by Fiscal Year
	Total		2012		2013		2014		2015		2016		Thereafter
Fixed rate debt	$	22,000	$	2,000	$	—	$	—	$	—	$	20,000	$	—
Variable rate debt	$	17,950	$	1,500	$	1,500	$	—	$	—	$	14,950	$	—

Based on borrowing rates currently available to use for loans with similar terms, the carrying value of our debt obligations approximates fair value.

ITEM 4. CONTROLS AND PROCEDURES

The term “disclosure controls and procedures” refers to the controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our Chief Executive Officer and Acting Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Acting Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e), as amended) as of December 31, 2011. Based upon that evaluation, our Chief Executive Officer and Acting Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2011.

There have been no significant changes in our internal controls or in other factors that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended December 31, 2011.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On January 31, 2007, we filed a claim against Phostech Lithium Inc. in the Federal Court in Canada (Valence Technology, Inc. v. Phostech Lithium Inc. Court File No. T-219-07) alleging infringement of our Canadian Patent 2,395,115 (‘115 Patent). Subsequently, on April 2, 2007, we filed an amended claim alleging additional infringement of our Canadian Patents 2,483,918 (‘918 Patent) and 2,466,366 (‘366 Patent). The trial took place in September 2010 and ended on October 1, 2010. On February 17, 2011, the Canadian Court ruled in our favor, finding that Phostech infringed our ‘115 Patent. The ‘918 Patent was held invalid. The ‘366 Patent was not held invalid, but no decision was rendered with respect to the infringement of the ‘366 Patent. An immediate injunction was imposed by the Trial Court on Phostech. Phostech twice appealed the imposition of the injunction and on the second appeal, the injunction was stayed by the Appellate Court, provided an expedited appeal would be undertaken and a bond posted by Phostech. The Appeal was heard on June 6, 2011. The Appellate Court denied the Appeal and affirmed the Trial Court Decision. The affirmation of the Trial Court’s decision permits us to seek monetary damages, reasonable attorney fees, costs and reinstated the injunction to stop Phostech from manufacturing, using and selling phosphate cathode material that infringes our valid Canadian Patent 2,395,115. On October 7, 2011, we received a payment from Phostech of $532,388 for attorney's fees incurred by us during the litigation with Phostech, as determined by the Trial Court order dated September 7, 2011. This payment is reflected as a reduction of general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss during the nine month period ended December 31, 2011. During the three month period ended December 31, 2011, we received an additional $251,709 from Phostech as a partial payment of damages, and the determination of additional damages is continuing. This payment was reflected in interest and other income in our condensed consolidated statement of operations and comprehensive loss during the three and nine month periods ended December 31, 2011.

On February 14, 2006, Hydro-Quebec filed an action against us in the United States District Court for the Western District of Texas (Hydro-Quebec v. Valence Technology, Civil Action No. A06CA111). An amended complaint was filed April 13, 2006. A stay imposed due to the USPTO reexaminations of the two patents was lifted following completion of the reexaminations. On January 8, 2009, Hydro-Quebec filed a second amended complaint, wherein Hydro-Quebec alleges that the cathode technology utilized in all of our commercial products infringes U.S. Reexamined Patent Nos. 5,910,382 and 6,514,640 exclusively licensed to Hydro-Quebec. Hydro-Quebec seeks injunctive relief and monetary damages. We have filed a response denying the allegations in the second amended complaint. A Markman hearing to determine the scope of the asserted claims in the two reexamined patents was completed in January 2010. The Special Master submitted recommended findings from the Markman Hearing to the Court in August 2010 and a Court hearing was held on those findings in November 2010. On April 27, 2011, the Court issued its order adopting the report of the Special Master. The Court set a trial date for October 2012. The case is now in the discovery phase.

On October 4, 2011, we were served with a complaint filed by Hydro-Quebec in the United States District Court for the Northern District of Texas (Hydro-Quebec v. A123 Systems, Inc., Valence Technology, Inc., Segway, Inc., and Texas Seg LLC., Civil Action No. 3:11-CV-1217 B). Hydro-Quebec seeks injunctive relief and monetary damages. The Complaint alleges that we are infringing five US Patents of the University of Texas. The five US Patents are all related to and continuations of the original UT Patent of Goodenough that has been asserted in the above-noted litigation in the Austin, Texas Federal District Court. We intend to vigorously defend against the allegations in the complaint and has filed a Motion to Transfer the Case to the Western District of Texas in Austin, Texas.

We are subject, from time to time, to various claims and litigation in the normal course of business. In our opinion, all pending legal matters will not have a material adverse impact on our consolidated financial statements. However, the outcome of any litigation is inherently uncertain and there can be no assurance as to the ultimate outcome of any such legal matters.

ITEM 1A. RISK FACTORS

In addition to the risk factors included in Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the SEC on May 26, 2011, the following additional or updated risk factors are applicable:

We depend on a small number of customers for a substantial portion of our revenues, and our results of operations and financial condition could be harmed if we were to lose all or a part of the business from any one of them.

To date, our existing purchase orders in commercial quantities are from a limited number of customers. During the fiscal year ended March 31, 2011, Smith Electric Vehicles ("Smith") and Segway Inc. contributed 42% and 24% of our revenues, respectively. During the three month period ended December 31, 2011, Segway, Howard Medical Solutions, Rubbermaid Medical Solutions, and PVI and represented 20%, 14%, 16% and 16% of our revenues, respectively. In the three months ended December 31, 2011 Smith contributed zero percent of our revenues. We anticipate that sales of our products to a limited number of key customers will continue to account for a significant portion of our total revenues although the identity of our key customers may change from period to period. We do not have long-term agreements with any of our key customers committing them to purchase any specified amount of our products. As a result, we face the substantial risk that one or more of the following events could occur:

●	reduction, delay or cancellation of orders from a customer;

●	development by a customer of other sources of supply;

●	selection by a customer of devices manufactured by one of our competitors for inclusion in future product generations;

●	loss of a customer or a disruption in our sales and distribution channels; or

●	failure of a customer to make timely payment of our invoices.

If we were to lose one or more customers, or if we were to lose revenues due to a customer’s inability or refusal to continue to purchase our batteries, or if we are not able to collect amounts owed to us by existing or former customers, our business, results of operations and financial condition would be harmed.

We are not currently in compliance with the continued listing requirements of the NASDAQ Capital Market and our common stock could be de-listed if we do not regain compliance within the required time period.

On December 13, 2011, we received written notice from The NASDAQ Stock Market indicating that we were not in compliance with the $1.00 minimum bid price requirement for continued listing on The NASDAQ Capital Market, as set forth in Listing Rule 5550(a)(2). We have been provided 180 calendar days, or until June 11, 2012, to regain compliance. To regain compliance, the bid price of our common stock must close at $1.00 or higher for a minimum of 10 consecutive business days within the stated 180-day period. If we are not in compliance by June 11, 2012, we may be afforded a second 180 calendar day grace period if we meet the NASDAQ Capital Market initial listing criteria (except for the minimum bid price requirement), as set forth in Listing Rule 5810(c)(3)(A). If we otherwise meet the initial listing criteria, NASDAQ will notify us that we have been granted such additional 180 calendar day compliance period. If we do not regain compliance within the allotted compliance period(s), including any extensions that may be granted by NASDAQ, our common stock will be subject to delisting from the NASDAQ Capital Market. We would then be entitled to appeal the NASDAQ Staff’s determination to a NASDAQ Listing Qualifications Panel and request a hearing. Since December 13, 2011, our closing stock price has been both above and below $1.00 per share and we have not yet regained compliance with the NASDAQ listing requirement. Given the volatility of our stock and trends in the stock market in general, there can be no assurance that we will regain compliance with the NASDAQ listing requirement. If we are not able to regain compliance, our stock could be de-listed and it could have a materially adverse effect on the price and liquidity of our common stock.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. [REMOVED AND RESERVED]

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Number	Description of Exhibit	Method of Filing

3.1	Second Restated Certificate of Incorporation of the Registrant	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

3.2	Certificate of Amendment to the Second Restated Certificate of Incorporation of the Registrant as filed with the Secretary of State of the State of Delaware on June 14, 2001	Incorporated by reference to the exhibit so described in the Registrant’s Schedule 14A filed with the Securities and Exchange Commission on January 28, 2000.

3.3	Certificate of Amendment to the Second Restated Certificate of Incorporation of the Registrant as filed with the Secretary of State of the State of Delaware on November 5, 2004	Incorporated by reference to the exhibit so described in the Registrant’s Form S-3 Registration Statement (File No. 333-171663) filed with the Securities and Exchange Commission on January 12, 2011.

3.4	Fourth Amended and Restated Bylaws of the Registrant, as currently in effect	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K dated January 18, 2008, filed with the Securities and Exchange Commission on January 22, 2008.

4.1	Specimen Common Stock Certificate of the Registrant	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

4.2	Certificate of Designations, Preferences and Rights of Series C-1 Convertible Preferred Stock of the Registrant	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K dated November 30, 2004, filed with the Securities and Exchange Commission on December 1, 2004.

4.3	Certificate of Designations, Preferences and Rights of Series C-2 Convertible Preferred Stock of the Registrant	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K dated November 30, 2004, filed with the Securities and Exchange Commission on December 1, 2004.

4.4	Warrant to Purchase Common Stock, issued March 30, 2010 to iStar Tara LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated April 5, 2010, filed with the Securities and Exchange Commission on April 5, 2010.

4.5	Warrant to Purchase Common Stock, issued January 11, 2011 to iStar Tara LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated January 11, 2011, filed with the Securities and Exchange Commission on January 12, 2011.

4.6	First Amendment to Warrant to Purchase Common Stock, issued March 30, 2010 to iStar Tara LLC, dated December 9, 2011.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 22, 2011, filed with the Securities and Exchange Commission on December 23, 2011.

4.7	First Amendment to Warrant to Purchase Common Stock, issued January 11, 2011 to iStar Tara LLC, dated December 9, 2011.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 22, 2011, filed with the Securities and Exchange Commission on December 23, 2011.

Number		Description of Exhibit	Method of Filing

10.1		Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated July 17, 1990	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

10.2		Amendment No. 1 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated March 15, 1991 (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

10.3		Amendment No. 2 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated March 24, 1992 (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

10.4		Amendment No. 3 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated August 17, 1992 (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Form S-1 Registration Statement (Registration No. 33-46765), as amended, filed with the Securities and Exchange Commission on March 27, 1992.

10.5		Amendment No. 4 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated September 1, 1997 (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2003, filed with the Securities and Exchange Commission on June 30, 2003.

10.6	*	1996 Non-Employee Directors’ Stock Option Plan as amended on October 3, 1997	Incorporated by reference to the exhibit so described in the Registrant’s Registration Statement on Form S-8 (File No 333-43203) filed with the Securities and Exchange Commission on December 24, 1997.

10.7	*	Notice of Grant of Stock Option and Stock Option Agreement under 1996 Stock Option Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011.

10.8	*	1997 Non-Officer Stock Option Plan	Incorporated by reference to the exhibit so described in the Registrant’s Registration Statement on Form S-8 (File No. 333-67693) filed with the Securities and Exchange Commission on November 20, 1998.

10.9		Amendment No. 5 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated July 17, 1998 (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K dated July 27, 1998, filed with the Securities and Exchange Commission on August 4, 1998.

10.10	*	Amended and Restated 2000 Stock Option Plan	Incorporated by reference to the exhibit so described in the Registrant’s Registration Statement on Form S-8 (File No. 333-101708) filed with the Securities and Exchange Commission on December 6, 2002.

10.11	*	Notice of Grant of Stock Option and Stock Option Agreement under 2000 Stock Option Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.12		Amendment No. 6 to Loan Agreement between the Registrant and Baccarat Electronics, Inc., dated November 27, 2000 (subsequently transferred to Berg & Berg Enterprises LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2003, filed with the Securities and Exchange Commission on June 30, 2003.

Number	Description of Exhibit	Method of Filing

10.13	Second Amended Promissory Note dated November 27, 2000 issued by the Registrant to Baccarat Electronics, Inc. (subsequently transferred to Berg & Berg Enterprises, LLC)	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2002, filed with the Securities and Exchange Commission on July 1, 2002.

10.14	Registration Rights Agreement with West Coast Venture Capital, Inc. (the 1981 Kara Ann Berg Trust) dated January 13, 2001	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2001, filed with the Securities and Exchange Commission on July 2, 2001.

10.15	Amendment No. 7 to Original Loan Agreement between the Registrant and Berg & Berg Enterprises, LLC (previously with Baccarat Electronics, Inc.), dated October 10, 2001	Incorporated by reference to the exhibit so described in the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2001, filed with the Securities and Exchange Commission on February 19, 2002.

10.16	Amendment No. 8 to Original Loan Agreement and Amendment to Second Amended Promissory Note between the Registrant and Berg & Berg Enterprises, LLC (previously with Baccarat Electronics, Inc.), dated February 11, 2002	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2002, filed with the Securities and Exchange Commission on July 1, 2002.

10.17	Loan Agreement dated October 5, 2001 between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2001, filed with the Securities and Exchange Commission on February 19, 2002.

10.18	Security Agreement dated October 5, 2001 between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2001, filed with the Securities and Exchange Commission on February 19, 2002.

10.19	Promissory Note dated October 5, 2001 issued by the Registrant to Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2001, filed with the Securities and Exchange Commission on February 19, 2002.

10.20	Amendment to Loan Agreements with Berg & Berg Enterprises, LLC dated November 8, 2002 (Amendment No. 1 to October 5, 2001 Loan Agreement and Amendment No. 9 to 1990 Baccarat Loan Agreement)	Incorporated by reference to the exhibit so described in the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2002, filed with the Securities and Exchange Commission on November 14, 2002.

10.21	Amendment to Loan Agreements with Berg & Berg Enterprises, LLC dated October 21, 2004 (Amendment No. 2 to October 5, 2001 Loan Agreement and Amendment No. 10 to 1990 Baccarat Loan Agreement)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated November 3, 2004, filed with the Securities and Exchange Commission on November 5, 2004.

10.23	Amendment to Loan Agreements with Berg and Berg Enterprises, LLC dated July 1, 2005 (Amendment No. 3 to October 5, 2001 Loan Agreement and Amendment No. 11 to 1990 Baccarat Loan Agreement)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 1, 2005, filed with the Securities and Exchange Commission on July 6, 2005.

10.24	Loan Agreement dated July 13, 2005, by and between the Registrant and SFT I, Inc.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 13, 2005, filed with the Securities and Exchange Commission on July 15, 2005.

Number		Description of Exhibit	Method of Filing

10.25		Registration Rights Agreement dated July 13, 2005 by and between the Registrant and SFT I, Inc.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 13, 2005, filed with the Securities and Exchange Commission on July 15, 2005.

10.26		Amendment to Loan Agreements with Berg and Berg Enterprises, LLC dated July 13, 2005 (Amendment No. 4 to October 5, 2001 Loan Agreement and Amendment No. 12 to 1990 Baccarat Loan Agreement)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 13, 2005, filed with the Securities and Exchange Commission on July 15, 2005.

10.27		Assignment Agreement, dated July 14, 2005, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 13, 2005, filed with the Securities and Exchange Commission on July 15, 2005.

10.28		Assignment Agreement, dated December 14, 2005, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 14, 2005, filed with the Securities and Exchange Commission on December 16, 2005.

10.29		Letter Agreement, effective March 13, 2007, by and between the Registrant and Robert L. Kanode	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated March 13, 2007, filed with the Securities and Exchange Commission on March 14, 2007.

10.30 **	*	FY 2011 Incentive Compensation and Stock Option Incentive Awards (Robert L. Kanode)	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.31		Supply Agreement dated February 6, 2008 by and between The Tanfield Group PLC and Valence Technology, Inc (portions of this contract have been omitted pursuant to a request for confidential treatment)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated February 6, 2008, filed with the Securities and Exchange Commission on February 12, 2008.

10.32		At Market Issuance Sales Agreement, dated February 22, 2008, by and between the Registrant and Wm Smith & Co.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated February 22, 2008, filed with the Securities and Exchange Commission on February 22, 2008.

10.33		Amendment to Loan Agreements with Berg and Berg Enterprises, LLC dated June 12, 2008 (Amendment No. 5 to October 5, 2001 Loan Agreement and Amendment No. 13 to 1990 Baccarat Loan Agreement)	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated June 12, 2008, filed with the Securities and Exchange Commission on June 16, 2008.

10.34	*	Employment Letter Agreement dated October 30, 2008, by and between Valence Technology Inc., and Koon Cheng Lim	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated November 4, 2008, filed with the Securities and Exchange Commission on November 4, 2008.

10.35	*	2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated May 6, 2009, filed with the Securities and Exchange Commission on May 6, 2009.

10.36	*	Notice of Grant of Stock Option and Stock Option Agreement under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

Number		Description of Exhibit	Method of Filing

10.37	*	Notice of Automatic Grant of Stock Option (Non-Employee Director) under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.38	*	Notice of Grant of Restricted Stock and Restricted Stock Issuance Agreement under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.39	*	Addendum to Stock Option Agreement regarding Involuntary Termination Following a Change of Control under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.40	*	Addendum to Restricted Stock Issuance Agreement regarding Involuntary Termination Following a Change of Control under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2011, filed with the Securities and Exchange Commission on May 26, 2011

10.41		Form of Indemnification Agreement entered into between the Registrant and its Directors and Officers	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated May 6, 2009, filed with the Securities and Exchange Commission on May 6, 2009.

10.42		Amendment No. 1 to At Market Issuance Sales Agreement, dated July 2, 2009, by and between the Registrant and Wm Smith & Co.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated July 6, 2009, filed with the Securities and Exchange Commission on July 6, 2009.

10.43		(Omnibus) Amendment No. 14 to Loan Agreement dated July 17, 1990 between the Registrant and Baccarat Electronics, Inc. (subsequently transferred to Berg & Berg Enterprises, LLC) and Amendment No. 6 to Loan Agreement dated October 5, 2001 between the Registrant and Berg & Berg Enterprises, LLC, each dated as of October 13, 2009	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated October 13, 2009, filed with the Securities and Exchange Commission on October 14, 2009.

10.44	*	Employment Letter Agreement by and between the Registrant and Randall J. Adleman	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, effective March 1, 2010, filed with the Securities and Exchange Commission on February 17, 2010.

10.45		Letter Agreement, dated February 22, 2010, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated February 24, 2010, filed with the Securities and Exchange Commission on February 24, 2010.

10.46		Amendment No. 2 to Loan and Security Agreement and Other Loan Documents dated March 30, 2010 by and among the Registrant, Carl Berg and iStar Tara LLC, successor in interest to SFT I, Inc.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated April 5, 2010, filed with the Securities and Exchange Commission on April 5, 2010.

10.47		Amendment No. 2 to At Market Issuance Sales Agreement, dated December 30, 2010, by and between the Registrant and Wm Smith & Co.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 30, 2010, filed with the Securities and Exchange Commission on December 30, 2010.

10.48		Amendment No. 3 to Loan and Security Agreement and Other Loan Documents dated January 11, 2011 by and among the Registrant, Carl Berg and iStar Tara LLC, successor in interest to SFT I, Inc.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated January 11, 2011, filed with the Securities and Exchange Commission on January 12, 2011.

Number	Description of Exhibit	Method of Filing

10.49	Letter Agreement, dated August 26, 2010, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated August 26, 2010, filed with the Securities and Exchange Commission on August 30, 2010.

10.50	Letter Agreement, dated September 28, 2010, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated September 28, 2010, filed with the Securities and Exchange Commission on September 30, 2010.

10.51	Letter Agreement, dated December 3, 2010, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 3, 2010, filed with the Securities and Exchange Commission on December 6, 2010.

10.52	Letter Agreement, dated August 15, 2011, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated August 15, 2011, filed with the Securities and Exchange Commission on August 16, 2011.

10.53	Amendment No. 4 to Loan and Security Agreement and Other Loan Documents dated December 22, 2011 by and among the Registrant, Carl Berg and iStar Tara LLC, successor in interest to SFT I, Inc.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated December 22, 2011, filed with the Securities and Exchange Commission on December 23, 2011.

10.54	Amendment No. 3 to At Market Issuance Sales Agreement, dated January 22, 2011, by and between the Registrant and Wm Smith & Co.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated January 22, 2011, filed with the Securities and Exchange Commission on January 24, 2011.

10.55	Amendment No. 4 to At Market Issuance Sales Agreement, dated June 17, 2011, by and between the Registrant and Wm Smith & Co.	Incorporated by reference to the exhibit so described in the Registrant’s Current Report on Form 8-K, dated June 17, 2011, filed with the Securities and Exchange Commission on June 20, 2011.

10.56	(Omnibus) Amendment No. 15 to Loan Agreement dated July 17, 1990 between the Registrant and Baccarat Electronics, Inc. (subsequently transferred to Berg & Berg Enterprises, LLC) and Amendment No. 7 to Loan Agreement dated October 5, 2001 between the Registrant and Berg & Berg Enterprises, LLC, each dated as of July 27, 2011	Incorporated by reference to the exhibit so described in the Registrant's Current Report on Form 8-K, dated July 27, 2011, filed with the Securities Exchange Commission on July 28, 2011.

10.57	Letter Agreement, dated January 13, 2012, by and between the Registrant and Berg & Berg Enterprises, LLC	Incorporated by reference to the exhibit so described in the Registrant's Current Report on Form 8-K, dated January 13, 2012, filed with the Securities Exchange Commission on January 18, 2012.

10.58	* Performance Based Restricted Stock Unit Award Agreement under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant's Current Report on Form 8-K, dated September 15, 2011, filed with the Securities Exchange Commission on September 21, 2011.

10.59	* Restricted Stock Unit Award Agreement under 2009 Equity Incentive Plan	Incorporated by reference to the exhibit so described in the Registrant's Current Report on Form 8-K, dated September 15, 2011, filed with the Securities Exchange Commission on September 21, 2011.

Number		Description of Exhibit	Method of Filing

31.1		Certification of Robert L. Kanode, Principal Executive Officer, pursuant to Exchange Act Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.

31.2		Certification of Donald E. Gottschalk, Principal Financial Officer, pursuant to Exchange Act Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.

32.1		Certification of Robert L. Kanode, Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed herewith.

32.2		Certification of Donald E. Gottschalk, Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed herewith.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema

101.CAL		XBRL Taxonomy Extension Calculation

101.DEF		XBRL Taxonomy Extension Definition

101.LAB		XBRL Taxonomy Extension Label

101.PRE		XBRL Taxonomy Extension Presentation

	*	Compensation plans or arrangements in which directors or executive officers are eligible to participate.

	**	Confidential treatment has been requested for portions of this exhibit and the confidential portions have been redacted and omitted from this filing, and the redacted portions have been separately filed with the Securities and Exchange Commission.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

	VALENCE TECHNOLOGY, INC.

Date: February 8, 2012	By:	/s/ Robert L. Kanode
		Robert L. Kanode Chief Executive Officer


Date: February 8, 2012	By:	/s/ Donald E. Gottschalk
		Donald E. Gottschalk Acting Chief Financial Officer